Abstract
Abstract
Purpose
Candida auris, an emerging multidrug-resistant yeast, has been reported worldwide. In Italy, the first case was reported in 2019. We describe the first case of C. auris, imported from Greece, in Milan, using whole genome sequencing to characterise mutations associated with antifungal resistance.
Case presentation
On October 2022 an 80-year-old Italian man was hospitalised in Greece. In the absence of clinical improvement, the patient was transferred to our hospital, in Italy, where blood culture resulted positive for C. auris. Despite therapy, the patient died of septic shock. In a phylogenetic analysis the genome was assigned to Clade I with strains from Kenya, United Arab Emirates and India. D1/D2 region resulted identical to a Greek strain, as for many other strains from different World regions, highlighting the diffusion of this strain.
Conclusion
Importation of C. auris from abroad has been previously described. We report the first case of C. auris imported into Italy from Greece, according to phylogenetic analysis. This case reinforces the need for monitoring critically ill hospitalised patients also for fungi and addresses the need for the standardisation of susceptibility testing and strategies for diagnosis and therapy.
Funder
Università degli Studi di Milano
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Ademe M, Girma F. Candida auris: from multidrug resistance to pan-resistant strains. Infect Drug Resist. 2020;5(13):1287–94. https://doi.org/10.2147/IDR.S249864. (PMID:3 2440165; PMCID: PMC7211321).
2. Kohlenberg A, Monnet DL, Plachouras D, Candida auris survey collaborative group; Candida auris survey collaborative group includes the following national experts. Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846. https://doi.org/10.2807/1560-7917.ES.2022.27.46.2200846.
3. Centers for Disease Control and Prevention. Increasing Threat of Spread of Antimicrobial-resistant Fungus in Healthcare Facilities. CDC Newsroom Releases. Mar 2023. https://www.cdc.gov/media/releases/2023/p0320-cauris.html. Accessed 23 Jan 2024
4. Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, et al. Worsening Spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 2023;176(4):489–95. https://doi.org/10.7326/M22-3469. (Epub 2023 Mar 21 PMID: 36940442).
5. Ceballos-Garzon A, Garcia-Effron G, Cordoba S, Rodriguez JY, Alvarez-Moreno C, Pape PL, Parra-Giraldo CM, Morales-López S. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing. Int J Antimicrob Agents. 2022;59(4):106558. https://doi.org/10.1016/j.ijantimicag.2022.106558. (Epub 2022 Feb 25. PMID: 35227828).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Caspofungin;Reactions Weekly;2024-09-07